Evaluation of the Effect of Saffron (Crocus Sativus) on Pain Control After Root Canal Therapy in Teeth With Vital Pulps
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this study is to determine whether saffron is effective in the pain control after root canal therapy in vital teeth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedFirst Posted
Study publicly available on registry
May 3, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedJanuary 29, 2013
January 1, 2013
8 months
April 27, 2012
January 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in VAS score
Patients will record their pain intensity in each time period according to Visual Analog Scale (VAS)
Every 6 hours after treatment completion up to 48 hours
Study Arms (2)
Starch capsule
PLACEBO COMPARATORstarch with dose of 100 mg in each capsule every 6 hours up to 48 hours (400 mg/day)
Saffron capsule
ACTIVE COMPARATORsaffron with dose of 100 mg in each capsule every 6 hours up to 48 hours (400 mg/day)
Interventions
Eligibility Criteria
You may qualify if:
- patients who have at least one vital tooth with one root canal and moderate to severe pain
You may not qualify if:
- teeth with periapical lesions
- patients with history of:
- allergy to saffron
- diabetes mellitus
- cardiovascular disorders
- kidney and liver diseases
- blood and hormonal disorders
- electrolyte imbalance
- women in pregnancy or breast feeding period and
- use of analgesics or opioids during 4 hours before treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zahedan university of medical sciences, Vice-chancellor for research
Zahedan, 98167-43463, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kaveh Oloomi, DDS, MS
Zahedan University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 27, 2012
First Posted
May 3, 2012
Study Start
May 1, 2012
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
January 29, 2013
Record last verified: 2013-01